Alibaba Health Information Technology Ltd banner
A

Alibaba Health Information Technology Ltd
HKEX:241

Watchlist Manager
Alibaba Health Information Technology Ltd
HKEX:241
Watchlist
Price: 3.35 HKD -3.46%
Market Cap: HK$54.2B

Wall St Price Targets

Price Targets Summary
Alibaba Health Information Technology Ltd

Wall Street analysts forecast Alibaba Health Information Technology Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Alibaba Health Information Technology Ltd is 5.47 HKD with a low forecast of 3.64 HKD and a high forecast of 8.4 HKD.

Lowest Forecast
Price Target
3.64 HKD
9% Upside
Average Forecast
Price Target
5.47 HKD
63% Upside
Highest Forecast
Price Target
8.4 HKD
151% Upside
Alibaba Health Information Technology Ltd Competitors:
Price Targets
ETR
Entergy Corp
8% Upside
VASTB
Vastned Belgium NV
8% Upside
OLPX
Olaplex Holdings Inc
0% Upside

Revenue
Forecast

40% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
40% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 40%. The projected CAGR for the next 8 years is 12%.

Gross Profit
Forecast

48% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
48% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 48%. The projected CAGR for the next 8 years is 14%.

Operating Income
Forecast

N/A
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
15%
Average Beat
N/A
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
15%
Average Beat

The compound annual growth rate for Operating Income over the next 6 years is 23%.

Pre-Tax Income
Forecast

N/A
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
N/A
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

The compound annual growth rate for Pre-Tax Income over the next 3 years is 31%.

Net Income
Forecast

N/A
Past Growth
27% / Year
Estimated Growth
Estimates Accuracy
-26%
Average Miss
N/A
Past Growth
27% / Year
Estimated Growth
Estimates Accuracy
-26%
Average Miss

The compound annual growth rate for Net Income over the next 6 years is 27%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Alibaba Health Information Technology Ltd's stock price target?
Price Target
5.47 HKD

According to Wall Street analysts, the average 1-year price target for Alibaba Health Information Technology Ltd is 5.47 HKD with a low forecast of 3.64 HKD and a high forecast of 8.4 HKD.

What is the Revenue forecast for Alibaba Health Information Technology Ltd?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Revenue has been 40%. The projected CAGR for the next 8 years is 12%.

What is the Gross Profit forecast for Alibaba Health Information Technology Ltd?
Projected CAGR
14%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 48%. The projected CAGR for the next 8 years is 14%.

What is the Operating Income forecast for Alibaba Health Information Technology Ltd?
Projected CAGR
23%

The compound annual growth rate for Operating Income over the next 6 years is 23%.

What is the Pre-Tax Income forecast for Alibaba Health Information Technology Ltd?
Projected CAGR
31%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 31%.

What is the Net Income forecast for Alibaba Health Information Technology Ltd?
Projected CAGR
27%

The compound annual growth rate for Net Income over the next 6 years is 27%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett